{{Rsnum
|rsid=2659056
|Gene=KLK15
|Chromosome=19
|position=50832687
|Orientation=minus
|GMAF=0.2612
|Gene_s=KLK15
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 53.1 | 38.1 | 8.8
| HCB | 40.1 | 40.1 | 19.7
| JPT | 39.8 | 48.7 | 11.5
| YRI | 100.0 | 0.0 | 0.0
| ASW | 91.2 | 8.8 | 0.0
| CHB | 40.1 | 40.1 | 19.7
| CHD | 35.2 | 47.2 | 17.6
| GIH | 68.3 | 27.7 | 4.0
| LWK | 99.1 | 0.9 | 0.0
| MEX | 44.8 | 32.8 | 22.4
| MKK | 96.8 | 3.2 | 0.0
| TSI | 61.8 | 32.4 | 5.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=22132073
|Title=Association between Prostinogen (KLK15) Genetic Variants and Prostate Cancer Risk and Aggressiveness in Australia and a Meta-Analysis of GWAS Data
|OA=1
}}

{{PMID Auto
|PMID=19639606
|Title=Correcting "winner's curse" in odds ratios from genomewide association findings for major complex human diseases.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}